U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals November 1997

Download the Final Guidance Document Read the Federal Register Notice
Final
Docket Number:
FDA-1997-D-0265
Issued by:
Guidance Issuing Office
Center for Biologics Evaluation and Research
Center for Drug Evaluation and Research

Guidance for Industry

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-1997-D-0265.

 
Back to Top